Design, synthesis and anti-HIV evaluation of 5-alkyl- 6-(benzo[d][1,3]dioxol-5-alkyl)-2-mercaptopyrimidin-4(3H)-ones as potent HIV-1 NNRTIs
Yi-Ming Li,Rong-Hua Luo,Liu-Meng Yang,Si-Ming Huang,Sui-Yuan Li,Yu-Gui Zheng,Dong-Xuan Ni,Yi-Man Cui,Xing-Jie Zhang,Xiao-Li Li,Rui-Han Zhang,E Tang,Hong-Bin Zhang,Yong-Tang Zheng,Yan-Ping He,Wei-Lie Xiao
DOI: https://doi.org/10.1016/j.bioorg.2020.104041
IF: 5.307
2020-09-01
Bioorganic Chemistry
Abstract:<p>In order to discover and develop the new HIV-1 Centrist, a series of 5-alkyl-6-(benzo[d][1,3]dioxol-5-ylalkyl)-2-mercaptopyrimidin-4(<em>3H</em>)-ones was synthesized and screened for their in vitro cytotoxicity against HIV-1. Most of the compounds we synthetized showed high activity against wild-type HIV-1 strain (IIIB) while IC<sub>50</sub> values are in the range of 0.06-12.95μM. Among them, the most active HIV-1 inhibitor was compound 6-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(<em>3H</em>)-one <strong>(5b)</strong>, which exhibited similar HIV-1 inhibitory potency (IC<sub>50</sub> = 0.06μM, CC<sub>50</sub> = 96.23μM) compared with nevirapine (IC<sub>50</sub> = 0.04μM, CC<sub>50</sub> >200μM) and most of compounds exhibited submicromolar IC<sub>50</sub> values indicating they were specific RT inhibitors. The compounds <strong>5b</strong>, 6-(benzo[d] [1,3]dioxol-5-yl)-5-ethyl-2-((2-(4-hydroxyphenyl)-2-oxoethyl)thio)pyrimidin-4(<em>3H</em>)-one <strong>(5c)</strong> and 4-(2-((4-(benzo[d][1,3]dioxol-5-ylmethyl)-5-ethyl-6-oxo-1,6-dihydro pyrimidin-2-yl)thio)acetyl)phenylbenzo[d][1,3]dioxole-5-carboxylate <strong>(5r)</strong> were selected for further study. It was found that all of them had little toxicity to peripheral blood mononuclear cell (PBMC), and had a good inhibitory effect on the replication of HIV-1 protease inhibitor resistant strains, fusion inhibitor resistant strains and nucleosides reverse transcriptase inhibitor resistant strains, as well as on clinical isolates. Besides, compound <strong>5b</strong> and <strong>5c</strong> showed inhibition of HIV-1 RT RNA-dependent DNA polymerization activity and DNA-dependent DNA polymerization activity, while compound <strong>5r</strong> only showed inhibition of HIV DNA-dependent DNA polymerization activity, which was different from classical reverse transcriptase inhibitors. Our study which offered the preliminary structure-activity relationships and modeling studies of these new compounds has provided the valuable avenues for future molecular optimization.</p>
biochemistry & molecular biology,chemistry, organic